SpringWorks
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade SpringWorks 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SWTX
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor.
CEOSaqib Islam
CEOSaqib Islam
Employees368
Employees368
HeadquartersStamford, Connecticut
HeadquartersStamford, Connecticut
Founded2017
Founded2017
Employees368
Employees368
SWTX Key Statistics
Market cap3.47B
Market cap3.47B
Price-Earnings ratio-13.53
Price-Earnings ratio-13.53
Dividend yield—
Dividend yield—
Average volume5.62M
Average volume5.62M
High today$46.28
High today$46.28
Low today$46.09
Low today$46.09
Open price$46.19
Open price$46.19
Volume6.89M
Volume6.89M
52 Week high$62.00
52 Week high$62.00
52 Week low$28.21
52 Week low$28.21
SWTX News
TipRanks 3d
Springworks Therapeutics Holds Annual Stockholders MeetingConfident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive underval...
Analyst ratings
100%
of 6 ratingsBuy
0%
Hold
100%
Sell
0%
People also own
Based on the portfolios of people who own SWTX. This list is generated using Robinhood data, and it’s not a recommendation.